Evidence map›Paper›PMID 30298443›Full record

ArticleCerebellum (London, England)2019

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease.

Karsten Mueller, Robert Jech, Tommaso Ballarini, Štefan Holiga, Filip Růžička, Fabian A Piecha, Harald E Möller, Josef Vymazal, Evžen Růžička, Matthias L Schroeter

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Effects of levodopa on motor and cerebellar network connectivity in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Functional Connectome in Parkinson's Disease and Parkinsonism.Current neurology and neuroscience reports · 2021
    Review
  14. Functional Connectivity of the Cognitive Cerebellum.Frontiers in systems neuroscience · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karsten Mueller *Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. karstenm@cbs.mpg.de.
Robert Jech *Department of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. jech@cesnet.cz.
Tommaso BallariniMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Štefan HoligaMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Filip RůžičkaDepartment of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Fabian A PiechaMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Harald E MöllerMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Josef VymazalDepartment of Radiology, Na Homolce Hospital, Prague, Czech Republic.
Evžen RůžičkaDepartment of Neurology - Center for interventional therapy of movement disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Matthias L SchroeterMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Funding

Charles University in Prague PROGRES Q27Czech Science Foundation 16-13323SMichael J. Fox Foundation for Parkinson's Research MJFF-11362Parkinson's Disease Foundation PDF-IRG-1307
6 · The paper itself

Abstract

Levodopa has been the mainstay of symptomatic therapy for Parkinson's disease (PD) for the last five decades. However, it is associated with the development of motor fluctuations and dyskinesia, in particular after several years of treatment. The aim of this study was to shed light on the acute brain functional reorganization in response to a single levodopa dose. Functional magnetic resonance imaging (fMRI) was performed after an overnight withdrawal of dopaminergic treatment and 1 h after a single dose of 250 mg levodopa in a group of 24 PD patients. Eigenvector centrality was calculated in both treatment states using resting-state fMRI. This offers a new data-driven and parameter-free approach, similar to Google's PageRank algorithm, revealing brain connectivity alterations due to the effect of levodopa treatment. In all PD patients, levodopa treatment led to an improvement of clinical symptoms as measured with the Unified Parkinson's Disease Rating Scale motor score (UPDRS-III). This therapeutic effect was accompanied with a major connectivity increase between cerebellar brain regions and subcortical areas of the motor system such as the thalamus, putamen, globus pallidus, and brainstem. The degree of interconnectedness of cerebellar regions correlated with the improvement of clinical symptoms due to the administration of levodopa. We observed significant functional cerebellar connectivity reorganization immediately after a single levodopa dose in PD patients. Enhanced general connectivity (eigenvector centrality) was associated with better motor performance as assessed by UPDRS-III score. This underlines the importance of considering cerebellar networks as therapeutic targets in PD.

Indexed as

AdultAgedAntiparkinson AgentsBrain MappingCerebellumFemaleHumansLevodopaMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysParkinson DiseaseRestAntiparkinson AgentsLevodopaBrain connectivityBrainstemCerebellar networksCerebellumDopaminergic treatmentEigenvector centralityFunctional connectivityL-dopaLevodopaNexopathyParkinson’s diseaseResting-state magnetic resonance imaging

Identifiers

PMID30298443
PMCPMC6443641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.